MMP1 and glioblastoma: In this study, we used biosensors previously constructed by our team based on the image version of the surface plasmon resonance technique for the quantitative determination of MMP-1, UCH-L1, and the 20S proteasome in the blood plasma of people with diagnosed glioblastomas and in a control group consisting of smokers of various ages.